|No.8 Jinshun Road Zhuqiao Pudong New District,Shanghai,Chinafirstname.lastname@example.org|
|Place of Origin:||Shanghai|
|Minimum Order Quantity:||10vial|
|Packaging Details:||Plastic Vial|
|Payment Terms:||L/C, T/T, D/P, , MoneyGram|
|Color:||White||Storage:||Dry Cool Place|
|Transport Package:||Plastic Vial(Dedicated For Peptide Packing) Or Gla||Appearence:||White Powder|
|Gonadorelin Assay:||98%||Packing:||10 Vials Per Kits|
peptides for muscle growth,
injectable human growth hormone
IGF-1 HGH Growth Hormone With 98% Purity 10 Vials Per Kits For Muscle Growth
|Product Name||IGF-1 (1-3)||CAS No.|
|Molecular Formula||C12H19N3O6||Batch No.||P160627-YS197068|
|Molecular Weight||301.3||Manufacturing Date||27/06/16|
|Storage||Cool dry place||Retest Date||27/06/16|
|1||Appearance||White powder||White powder|
|2||Solubility||Soluble in water or acetic acid at a to give a clear, colorless solution||Conforms|
|3||Amino Acid Composition||±10% of theoretical||Conforms|
|4||Peptide Purity (By HPLC)||³98.0% by area integration||99.06%|
|5||Related Substance(By HPLC)||
Largest Single Impurity(%)£1.0%
|6||Acetate Content (By HPLC)||£15.0%||12.4%|
|7||Water Content(Karl Fischer)||£8.0%||4.8%|
Peptide Content (N determination)
|10||Assay(By Anhydrous, Acetic Acid-free )||95.0～105.0%||98.45%|
A deregulation or imbalance in the IGF system could have implications in a number of different disorders including perturbations with normal growth, cancer and diabetes. As such, the IGF protein family continues to be a viable target for new therapeutic agents.
In newborns, basal IGF-1 levels are low, but as humans develop, the GH feedback loop and the regulation of IGF-1 become more pronounced.7 Circulating IGF-1 stimulates growth in all cells, from skeletal muscle and bone to organ tissue and vessel linings.2 Circulating levels of IGF-1 vary greatly depending on a number of intrinsic and extrinsic factors, including age, gender, genetics, nutritional status, physical activity and stress.7 Due to the tightly controlled relationship between IGF-1 and GH, a deficiency or excess in either hormone can result in physiological errors in metabolism such as dwarfism, pituitary gigantism and acromegaly.
Dwarfism can result from a mutation in the hepatic GH receptor which yields insensitivity to secreted GH. As a consequence, IGF-1 is synthesized and secreted at suboptimal levels. With outright GH deficiency, the pituitary does not produce enough GH, which negatively impacts IGF-1 levels.
Pituitary gigantism arises from excessive GH and IGF-1 prior to growth plate fusion. Should hormone excess present after epiphyseal plate fusion, the condition is referred to as acromegaly. Both disorders are extremely rare and symptoms can be intermittent, often confounded by coexisting conditions. The common therapeutic approach for these disorders is aimed at regulating circulating GH and IGF-1 levels using recombinant hormone therapy, but ongoing in vitro and in vivo studies are employing newer methods of treatment. To date, treatments have the greatest impact when started prior to puberty.
1) Helps regulate fat for use as energy, resulting in fat loss.
2).Contributes to anti aging. As we get older, IGF-1 production slows down and this
results in cell reduction. Low levels of IGF-1 are linked to heart failure, lower brain
cell regulation and neuron function. Not to mention muscle tissue breakdown.
3).Helps to increase nutrient shuttling (protein synthesis).
4).Increases regenerative functions of nerve tissues.
5).Boosts the ability to cause hyperplasia in muscle cells resulting in fuller muscle
1.COA HPLC MS be sent on request
Delivery: Immediately by DHL/EMS/TNT within 10 days (If you have Forwarder in China, it is better.)
2) Payment Terms: Bank Transfer,MoneyGram and .
Please feel free to contact us if you have any other requirement, we accept custom-made.Most competitive price, best quality and best service will be provided.
Our Peptide Lab:
*If you have any interest on any of the above peptides, welcome to contact us
Contact Person: Qin